JP3417650B2 - Toothpaste composition - Google Patents
Toothpaste compositionInfo
- Publication number
- JP3417650B2 JP3417650B2 JP07662694A JP7662694A JP3417650B2 JP 3417650 B2 JP3417650 B2 JP 3417650B2 JP 07662694 A JP07662694 A JP 07662694A JP 7662694 A JP7662694 A JP 7662694A JP 3417650 B2 JP3417650 B2 JP 3417650B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- dentifrice composition
- composition
- polyoxyethylene
- toothpaste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 27
- 239000000606 toothpaste Substances 0.000 title claims description 13
- 229940034610 toothpaste Drugs 0.000 title claims description 12
- 239000000551 dentifrice Substances 0.000 claims description 18
- -1 polyoxypropylene Polymers 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- 229920001451 polypropylene glycol Polymers 0.000 claims description 8
- 239000000377 silicon dioxide Substances 0.000 claims description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 229920000388 Polyphosphate Polymers 0.000 claims description 6
- 229920001400 block copolymer Polymers 0.000 claims description 6
- 239000001205 polyphosphate Substances 0.000 claims description 6
- 235000011176 polyphosphates Nutrition 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 5
- 238000013329 compounding Methods 0.000 claims description 3
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 description 22
- 230000000844 anti-bacterial effect Effects 0.000 description 14
- 238000004040 coloring Methods 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- 235000020279 black tea Nutrition 0.000 description 3
- 230000007505 plaque formation Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、塩酸アルキルジアミノ
エチルグリシンを含有する歯磨組成物において、塩酸ア
ルキルジアミノエチルグリシンの殺菌活性を安定に保つ
とともに、塩酸アルキルジアミノエチルグリシンによる
歯牙および義歯の着色を防止し、外観にも優れた歯磨組
成物に関する。FIELD OF THE INVENTION The present invention relates to a dentifrice composition containing alkyldiaminoethylglycine hydrochloride, in which the bactericidal activity of alkyldiaminoethylglycine hydrochloride is kept stable and the coloring of teeth and dentures with alkyldiaminoethylglycine hydrochloride is suppressed. The present invention relates to a dentifrice composition which is excellent in prevention and appearance.
【0002】[0002]
【従来の技術および課題】塩酸アルキルジアミノエチル
グリシン(以下、AGと略す)は、強力な殺菌作用によ
り歯垢形成抑制に有効であることが知られており、従来
より歯磨に配合されている。しかしながら、AGは、シ
リカ系研磨剤や発泡剤や粘結剤等の通常配合される歯磨
成分との相溶性が悪く、組成物に配合した際、AGの殺
菌活性が著しく低下するという問題がある。組成物中で
AGの殺菌活性を維持するために、例えば、粘結剤無配
合の歯磨剤が特開平2ー282317号に開示された
り、ノニオン性界面活性剤による失活を防止するために
フェノール系の化合物を配合する口腔用組成物が特開昭
60ー255717号に開示されている。しかしなが
ら、本発明者らの検討の結果では、上述の技術によって
AGの殺菌活性が維持される場合、歯磨の使用後、紅茶
などの色素沈着により、歯牙や義歯に着色が生じること
を知見した。さらに、特開昭60ー255717号で
は、他のアニオン性粘結剤を併用した場合、AGが著し
く失活し、その効果が十分に発揮されないことを知見し
た。2. Description of the Related Art Alkyldiaminoethylglycine hydrochloride (hereinafter abbreviated as AG) is known to be effective in suppressing plaque formation due to its strong bactericidal action, and has been conventionally blended in toothpaste. However, AG has a poor compatibility with commonly used toothpaste components such as silica-based abrasives, foaming agents and binders, and when incorporated into a composition, the bactericidal activity of AG is significantly reduced. . In order to maintain the bactericidal activity of AG in the composition, for example, a dentifrice without a binder is disclosed in JP-A-2-282317, and in order to prevent deactivation by a nonionic surfactant, phenol is used. An oral composition containing a compound of the above-mentioned type is disclosed in JP-A-60-255717. However, as a result of the study by the present inventors, it was found that, when the bactericidal activity of AG is maintained by the above-described technique, the teeth and the denture are colored due to the pigmentation of black tea after the use of toothpaste. Furthermore, in JP-A-60-255717, it was found that when other anionic binders were used in combination, AG was significantly deactivated and its effect was not fully exhibited.
【0003】本発明者らは、かかる事情を解決するため
に鋭意検討を行った。その結果、シリカ系研磨剤、特定
の界面活性剤、ポリリン酸塩を組み合わせることによ
り、AGの殺菌活性を安定に維持し、かつ、歯牙や義歯
の着色を防止し、性状安定性にも優れた歯磨組成物が得
られることを見出し、本発明を完成するに至った。The inventors of the present invention have made extensive studies in order to solve such a situation. As a result, by combining a silica-based abrasive, a specific surfactant, and a polyphosphate salt, the bactericidal activity of AG was stably maintained, and the teeth and artificial teeth were prevented from being colored, and the property stability was also excellent. The inventors have found that a dentifrice composition can be obtained, and completed the present invention.
【0004】[0004]
【課題を解決するための手段】すなわち、本発明はAG
を含有する歯磨組成物において、シリカ系研磨剤と特定
のポリオキシエチレン・ポリオキシプロピレンブロック
コポリマー界面活性剤およびポリリン酸塩を配合してな
ることを特徴とする歯磨組成物を提供するものである。
本発明の歯磨組成物によれば、AGの殺菌活性の低下が
効果的に防止され、歯垢形成の抑制及び歯肉炎の予防が
極めて効果的に行え、かつAGによる歯牙、義歯の着色
を防止できる。That is, the present invention provides AG
To provide a dentifrice composition containing a silica-based abrasive, a specific polyoxyethylene / polyoxypropylene block copolymer surfactant, and a polyphosphate salt in a dentifrice composition containing .
According to the dentifrice composition of the present invention, reduction of the bactericidal activity of AG is effectively prevented, plaque formation can be suppressed and gingivitis can be prevented very effectively, and tooth and denture coloring due to AG can be prevented. it can.
【0005】本発明に用いるAGの配合量は、特に制限
されないが、殺菌活性上また経済性から通常歯磨組成物
全体に対して0.001〜0.5重量%が好ましい。The blending amount of AG used in the present invention is not particularly limited, but is usually 0.001 to 0.5% by weight based on the whole dentifrice composition from the viewpoint of bactericidal activity and economical efficiency.
【0006】本発明に用いるシリカ系研磨剤は無水ケイ
酸、ケイ酸アルミニウム、ケイ酸ジルコニウム等が使用
され、その配合量は通常歯磨組成物全体に対して5〜3
0重量%が好ましい。配合量が30重量%を超えると、
粘度が高くなり、容器からの絞り出しが困難になるなど
の問題を生じ、5重量%未満であると、タバコヤニや紅
茶ステインなどの歯牙、義歯の着色・汚れ除去効果が不
十分である。As the silica-based abrasive used in the present invention, anhydrous silicic acid, aluminum silicate, zirconium silicate or the like is used, and the compounding amount thereof is usually 5 to 3 with respect to the whole dentifrice composition.
0% by weight is preferred. When the blending amount exceeds 30% by weight,
If the content is less than 5% by weight, the viscosity and the squeeze out of the container become difficult, and the effect of removing stains and stains on teeth such as tobacco tar and black tea stains and artificial teeth is insufficient.
【0007】本発明に用いるポリオキシエチレン・ポリ
オキシプロピレンブロックコポリマー界面活性剤は、一
般にポリオキシプロピレンの分子量とポリオキシエチレ
ンの分子中に占める重量%によって化学的に定義される
が、好ましいポリオキシエチレン・ポリオキシプロピレ
ンブロックコポリマーは、ポリオキシプロピレンの分子
量が1400〜4000で、かつ、分子中に占めるポリ
オキシエチレンの割合が30〜80重量%の範囲のもの
である。また、配合量は、特に制限されないが、通常歯
磨組成物全体に対して5〜11重量%であり、さらに好
ましくは、7〜9重量%である。配合量が11重量%を
超えると、ゲル化が起こり、シリカ系研磨剤によるゲル
化との相互作用で、固液分離による性状安定性の問題を
生じる。一方、5重量%未満であるとAGによる歯牙、
義歯への着色防止が不十分である。The polyoxyethylene / polyoxypropylene block copolymer surfactant used in the present invention is generally chemically defined by the molecular weight of polyoxypropylene and the weight% of the polyoxyethylene in the molecule. The ethylene / polyoxypropylene block copolymer has a molecular weight of polyoxypropylene of 1400 to 4000 and a proportion of polyoxyethylene in the molecule of 30 to 80% by weight. The blending amount is not particularly limited, but is usually 5 to 11% by weight, and more preferably 7 to 9% by weight, based on the whole dentifrice composition. When the blending amount exceeds 11% by weight, gelation occurs, and interaction with gelation by the silica-based abrasive causes a problem of property stability due to solid-liquid separation. On the other hand, if it is less than 5% by weight, teeth due to AG,
Insufficient prevention of coloration on dentures.
【0008】本発明に用いるポリリン酸塩としては、ピ
ロリン酸塩、トリポリリン酸塩、ヘキサメタリン酸塩等
が挙げられ、その塩としては、ナトリウム、カリウム等
が挙げられる。これらの化合物はその1種を単独で用い
ても2種以上を併用しても差し支えない。また、その配
合量は、通常歯磨組成物全体に対しても0.2〜4重量
%、好ましくは、0.4〜2重量%、さらに好ましくは
0.8〜1.2重量%である。配合濃度が4重量%を超
えると、口腔粘膜剥離等、口腔粘膜に対する安全上の問
題を生じ、一方、0.2重量%未満であるとAGによる
歯牙、義歯への着色防止が不十分である。Examples of the polyphosphate used in the present invention include pyrophosphate, tripolyphosphate, hexametaphosphate, and the like, and salts thereof include sodium and potassium. These compounds may be used alone or in combination of two or more. Further, the blending amount thereof is usually 0.2 to 4% by weight, preferably 0.4 to 2% by weight, more preferably 0.8 to 1.2% by weight, based on the whole dentifrice composition. If the concentration is more than 4% by weight, safety problems such as oral mucous membrane peeling will occur on the oral mucous membrane, while if less than 0.2% by weight, AG will not sufficiently prevent coloring of teeth and dentures. .
【0009】さらに、本発明の歯磨組成物は、歯牙用、
義歯用のいずれにおいても使用でき、常法にしたがっ
て、練歯磨、粉歯磨、液状歯磨、パスタ剤などの剤型に
することができ、必用に応じて適宜な成分、たとえばソ
ルビット、プロピレングリコール、グリセリン、ポリエ
チレングリコール等の湿潤剤、ペパーミント、スペアミ
ント等の精油、lーメントール、カルボン、アネトール
等の香料素材等の香料、サッカリンナトリウム、ステビ
オサイド、ネオヘスピリジルヒドロカルコン、グリチル
リチン、ソーマチン、ペリラルチン、Pーメトキシシン
ナミックアルデヒド等の甘味剤、カルボキシメチルセル
ロースナトリウム、カラギーナン、キサンタンガム、ア
ルギン酸ナトリウム、ヒドロキシエチルセルロース等の
粘結剤、およびフッ化ナトリウム、モノフルオロリン酸
ナトリウム、デキストラナーゼ、ムタナーゼ、ヒノキチ
オール、リゾチーム、アラントイン、グリチルリチン酸
ジカリウム、イプシロンアミノカプロン酸、トラネキサ
ム酸、ビタミンEおよびその誘導体、塩化ナトリウム、
アズレン等の有効成分を本発明の効果を損なわない範囲
で配合することができる。Furthermore, the dentifrice composition of the present invention is for teeth,
It can be used in any of dentures, and can be made into a dosage form such as toothpaste, powder toothpaste, liquid toothpaste, and pasta agent according to a conventional method, and if necessary, appropriate ingredients such as sorbit, propylene glycol, and glycerin. , Humectants such as polyethylene glycol, essential oils such as peppermint and spearmint, fragrances such as perfume materials such as l-menthol, carvone and anethole, sodium saccharin, stevioside, neohespiridyl hydrochalcone, glycyrrhizin, thaumatin, perillartin, P-methoxycinnamic Sweeteners such as aldehydes, sodium carboxymethyl cellulose, carrageenan, xanthan gum, sodium alginate, binders such as hydroxyethyl cellulose, and sodium fluoride, sodium monofluorophosphate, dex Ranaze, mutanase, hinokitiol, lysozyme, allantoin, dipotassium glycyrrhizinate, epsilon-aminocaproic acid, tranexamic acid, vitamin E and derivatives thereof, sodium chloride,
Active ingredients such as azulene may be added within a range that does not impair the effects of the present invention.
【0010】[0010]
実施例1〜7及び比較例1〜9
表1に示した処方により、常法に従って練歯磨を調製し
た。かくして得られた練歯磨について、その殺菌力と着
色性について以下に示す測定方法にて測定した。Examples 1 to 7 and Comparative Examples 1 to 9 Toothpastes were prepared according to a conventional method according to the formulations shown in Table 1. The toothpaste thus obtained was measured for its bactericidal activity and colorability by the following measuring methods.
【0011】(殺菌力試験)練歯磨をそれぞれ約1g秤
取し、蒸留水に懸濁した後、遠心分離により上清を得
た。得られた上清中のAG濃度が0.0015%、0.
003%および0.006%となるように蒸留水で希釈
した。一方、AGを蒸留水に溶解し、0.0015%、
0.003%および0.006%の濃度としたものを最
小殺菌濃度(%、以下MBCと略す)測定の際の標準と
して用いた。各調製試料10mlに108〜109CFU
/mlのストレプトコッカス・ミュータンス菌浮遊液0.
1mlを加え、湯浴中37℃にて3分間殺菌反応をおこ
なった。反応後、試料液を1白金耳採取し、ポリオキシ
エチレンモノオレート0.5%およびレシチン0.07%
含有トリプチナーゼ・ソイ・アガー(TSA)平板上に塗
布し、嫌気条件下(N2/H2/CO2=85/10/
5)にて37℃、2日間培養し、MBCを測定した。標
準のAGのMBCは、0.003%であった。評価は次
の基準に従っておこなった。
○:試験サンプルのMBCが 0.0015%または
0.0030%
△:試験サンプルのMBCが 0.0060%
X:試験サンプルのMBCが 0.0060%より大(Bactericidal test) About 1 g of each toothpaste was weighed, suspended in distilled water, and then centrifuged to obtain a supernatant. The AG concentration in the obtained supernatant was 0.0015%,
Diluted with distilled water to 003% and 0.006%. On the other hand, AG is dissolved in distilled water to obtain 0.0015%,
The concentration of 0.003% and 0.006% was used as a standard for measuring the minimum bactericidal concentration (%, hereinafter abbreviated as MBC). 10 8 to 10 9 CFU for 10 ml of each prepared sample
/ Ml Streptococcus mutans bacteria suspension 0.
1 ml was added, and a sterilization reaction was performed at 37 ° C. for 3 minutes in a hot water bath. After the reaction, 1 platinum loop of the sample solution was sampled and polyoxyethylene monooleate 0.5% and lecithin 0.07%
Containing tryptinase soy agar (TSA) on a flat plate and subjected to anaerobic conditions (N 2 / H 2 / CO 2 = 85/10 /
MBC was measured by culturing at 5) for 2 days at 37 ° C. The MBC of the standard AG was 0.003%. The evaluation was performed according to the following criteria. ◯: MBC of the test sample is 0.0015% or 0.0030% Δ: MBC of the test sample is 0.0060% X: MBC of the test sample is greater than 0.0060%
【0012】(着色性試験)旭光学製のハイドロキシア
パタイトディスクを練歯磨を蒸留水にて4倍に希釈した
スラリーに3分間浸漬させ、1分間水洗する。次に、デ
ィスクを紅茶抽出液に10分間浸漬させ、1分間水洗す
る。この操作を10回くり返し、試験開始前後でのディ
スクの色調を色差測定をおこなう。コントロールとし
て、練歯磨スラリーの代わりに蒸留水を用いた。色差
は、測色光度計にて測定した。評価は次の基準に従って
おこなった。
○:色差が10以下(コントロールのディスクと同等)
△:色差が10以上20未満
X:色差が20以上(Coloring Test) A hydroxyapatite disc manufactured by Asahi Optical Co., Ltd. is dipped in a slurry prepared by diluting a toothpaste 4 times with distilled water for 3 minutes and washed with water for 1 minute. Next, the disc is immersed in the black tea extract for 10 minutes and washed with water for 1 minute. This operation is repeated 10 times, and the color difference of the color tone of the disk before and after the test is measured. As a control, distilled water was used instead of the toothpaste slurry. The color difference was measured with a colorimeter. The evaluation was performed according to the following criteria. ◯: Color difference is 10 or less (equivalent to control disc) Δ: Color difference is 10 or more and less than 20 X: Color difference is 20 or more
【0013】(総合評価)総合評価は次の基準に従って
評価した。
○:殺菌力の評価が○ かつ 着色性の評価が○
X:殺菌力の評価が△かX あるいは 着色性の評価が
△かX
結果を表1に示す。(Comprehensive Evaluation) The comprehensive evaluation was evaluated according to the following criteria. ◯: Evaluation of bactericidal power is ◯ and evaluation of coloring property is ◯ X: Evaluation of bactericidal power is Δ or X, or evaluation of coloring property is Δ or X. Table 1 shows the results.
【0014】[0014]
【表1】 [Table 1]
【0015】表1に示すとおり、AGを含有する歯磨組
成物において、シリカ系研磨剤と特定のポリオキシエチ
レン・ポリオキシプロピレンブロックコポリマー界面活
性剤およびポリリン酸塩を配合することにより、AGの
殺菌活性低下が効果的に防止され、かつ、AGによる歯
牙、義歯の着色を防止した。As shown in Table 1, in a dentifrice composition containing AG, by combining a silica-based abrasive with a specific polyoxyethylene / polyoxypropylene block copolymer surfactant and polyphosphate, sterilization of AG is performed. The decrease in activity was effectively prevented, and coloring of teeth and dentures by AG was prevented.
【0016】[0016]
【発明の効果】本発明によれば、AGの殺菌活性低下が
効果的に防止され、歯垢形成の抑制及び歯肉炎の予防が
極めて効果的に行え、かつ、AGによる歯牙、義歯の着
色を防止できる。INDUSTRIAL APPLICABILITY According to the present invention, the reduction of the bactericidal activity of AG is effectively prevented, the formation of plaque and the prevention of gingivitis can be extremely effectively performed, and the coloring of teeth and dentures by AG is performed. It can be prevented.
フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 CA(STN) REGISTRY(STN)Continuation of the front page (58) Fields surveyed (Int.Cl. 7 , DB name) A61K 7/ 00-7/50 CA (STN) REGISTRY (STN)
Claims (5)
含有する歯磨組成物において、シリカ系研磨剤およびポ
リオキシプロピレンの分子量が1400〜4000であ
り、分子中にしめるポリオキシエチレンの割合が30〜
80重量%のポリオキシエチレンポリオキシプロピレン
ブロックコポリマー系界面活性剤およびポリリン酸塩を
配合してなることを特徴とする歯磨組成物1. In a dentifrice composition containing alkyldiaminoethylglycine hydrochloride, the silica-based abrasive and the polyoxypropylene have a molecular weight of 1400 to 4000, and the ratio of polyoxyethylene contained in the molecule is 30 to 40.
Toothpaste composition comprising 80% by weight of a polyoxyethylene polyoxypropylene block copolymer surfactant and a polyphosphate salt
配合量が組成物全体の0.001〜1重量%である特許
請求の範囲第1項記載の歯磨組成物2. The dentifrice composition according to claim 1, wherein the amount of alkyldiaminoethylglycine hydrochloride mixed is 0.001 to 1% by weight based on the total weight of the composition.
5〜30重量%である特許請求の範囲第1項乃至第2項
記載の歯磨組成物3. The dentifrice composition according to claim 1, wherein the amount of the silica-based abrasive compounded is 5 to 30% by weight based on the total weight of the composition.
レンブロックコポリマー系界面活性剤の配合量が組成物
全体の5〜11重量%である特許請求の範囲第1項乃至
第3項記載の歯磨組成物4. The dentifrice composition according to claim 1, wherein the compounding amount of the polyoxyethylene / polyoxypropylene block copolymer-based surfactant is 5 to 11% by weight of the total composition.
0.2〜4.0重量%である特許請求の範囲第1項乃至
第4項記載の歯磨組成物5. The dentifrice composition according to any one of claims 1 to 4, wherein the compounding amount of the polyphosphate salt is 0.2 to 4.0% by weight based on the whole composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP07662694A JP3417650B2 (en) | 1994-03-22 | 1994-03-22 | Toothpaste composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP07662694A JP3417650B2 (en) | 1994-03-22 | 1994-03-22 | Toothpaste composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH07258051A JPH07258051A (en) | 1995-10-09 |
| JP3417650B2 true JP3417650B2 (en) | 2003-06-16 |
Family
ID=13610580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP07662694A Expired - Fee Related JP3417650B2 (en) | 1994-03-22 | 1994-03-22 | Toothpaste composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3417650B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008156308A (en) * | 2006-12-26 | 2008-07-10 | Lion Corp | Oral composition |
| KR101013803B1 (en) * | 2008-11-11 | 2011-02-14 | (주)아모레퍼시픽 | Oral composition effective in preventing tartar formation |
| JP7799479B2 (en) * | 2021-12-24 | 2026-01-15 | サンスター株式会社 | Composition containing alkyldiaminoethylglycine and/or its salt |
-
1994
- 1994-03-22 JP JP07662694A patent/JP3417650B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07258051A (en) | 1995-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4674980B2 (en) | Alcohol-free liquid oral composition | |
| EP3139894B1 (en) | Oral care compositions | |
| JP5440150B2 (en) | Oral composition | |
| JP2002047157A (en) | Oral composition | |
| JP5196127B2 (en) | Oral composition | |
| JP2002114657A (en) | Base material for composition for oral cavity and composition for oral cavity | |
| JP5397204B2 (en) | Oral composition | |
| JPH03169810A (en) | Mouth application composition containing monoperoxy acids | |
| CN107205900A (en) | Dentifrice Composition | |
| JP7447470B2 (en) | dentifrice composition | |
| JP3417650B2 (en) | Toothpaste composition | |
| JP3854719B2 (en) | Oral composition | |
| JP2586896B2 (en) | Oral composition | |
| JP3815556B2 (en) | Oral composition | |
| JP2002255772A (en) | Base for composition for oral cavity and composition for oral cavity | |
| CN111315351B (en) | oral composition | |
| JP3241946B2 (en) | Oral composition | |
| JP3195150B2 (en) | Oral composition | |
| JP3961479B2 (en) | Liquid oral composition | |
| JP2001122746A (en) | Tooth paste composition | |
| JP3305108B2 (en) | Toothpaste composition | |
| JP7703910B2 (en) | Dentifrice Composition | |
| JP2003231621A (en) | Oral composition for preventing bad breath | |
| JP2002104945A (en) | Dentifrice composition | |
| JP3877412B2 (en) | Liquid oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20030318 |
|
| LAPS | Cancellation because of no payment of annual fees |